Clinical Research: Phase 1 - Phase 4
Proven Strategies for Rare Disease and Orphan Drug Development in the U.S.
Orphan drugs are medicinal products intended to treat diseases so rare that sponsors are reluctant to develop them under usual marketing conditions. Orphan drugs are a growing market, due in large part to tax incentives, longer periods of market exclusivity, and shorter, smaller clinical trials, as well as the premium pricing associated with many orphan...